Intensity of Microsporidia spores among HIV-infected patients and their Non-HIV-infected counterparts in a Tertiary Hospital in Nigeria.
DOI:
https://doi.org/10.37506/mbgdhg08Keywords:
Intensity, Microsporidia, patients, Nigeria.Abstract
Background: Microsporidia infection still remains a public health challenge in immuno-compromised subjects particularly in developing countries.
Objective: A study was carried out among HIV-infected patients at a University of Ilorin Teaching Hospital in Nigeria to determine the prevalence and intensity of microsporidiasis.
Methods: Seven hundred and fifty stool samples were collected from HIV-infected patients and 375 samples from their non-infected counterparts matched for age, sex and socio-economic variables. Microsporidia species were characterized morphologically, using Chromoptrope 2R staining technique. Pure microsporidia spores were isolated from the stool samples by the Ficoll-Hipaque technique. The size of microsporidial were confirmed by the comparison with the reference specimen (No. UN3373) obtained from the Center for Disease Control and Prevention (CDC) Atlanta, USA.
Results: The overall prevalence of microsporidia isolates in the stool samples of 750 HIV-infected patients was 42.4%. This infection rate was significantly higher than among the HIV-non-infected subjects (19.2%) (P<0.05). The intensity of microsporidia spores among HIV-infected patients (mean ± SD=176±52.3) was significantly higher than the intensity among the non-infected control group (mean ± SD=23±8.2) (P<0.05). This intensity spores among HIV-infected patients who were on HAART treatment and among those who were not on HAART treatment were similar. In general, the intensity of microsporidia spores by age, sex, marital status, occupation and education was significantly higher among HIV-infected patients than among their HIV-non-infected counterpart (P<0.05).
Conclusion: Microsporidiasis is prevalent among immuno-compromised (HIV/AIDS) patients with a very high intensity. Therefore, it is highly desirable that a drug of choice for the treatment of microsporidiasis should be developed. Health education campaigns to promote awareness, prevention and control of microsporidiasis should be mounted.
References
Didier, E.S., Stovall, M.E. and Green, L.C. (2004): Epidemiology of microsporidiosis: sources and modes of transmission. Veterinary Parasitology. 126:145.
Matsubyashi, M., Kioke, T., Mikata, I., Takei, H. and Hagiwara, S. (1959): A case of encephalitozoon-like body infection in man. Archives in Pathology. 67:73–79.
Batman, P.A., Kotler, D.P. and Kapembwa, M.S. (2007): HIV enteropathy: crypt stem and transit cell hyperproliferation induces villous atrophy in HIV/Microsporidia-infected jejunal mucosa. AIDS. 21:433.
Al-Brhami K, Abdul-Ghani R, Al-Qobati SA.( 2022): Intestinal microsporidiosis among
HIV/AIDS patients receiving antiretroviral therapy in Sana’a city, Yemen: first report on
prevalence and predictors. BMC Infectious Diseases, 22, 11.
Bojko J, Reinke AW, Stentiford GD, Williams B, Rogers M, Bass D. (2022): Microsporidia: a
new taxonomic, evolutionary, and ecological synthesis. Trends in Parasitology, 38, 642–659.
Ghoshal U, Kalra SK, Tejan N, Ranjan P, Dey A, Nityanand S. (2021): Prevalence and
Genetic Characterization of Cryptosporidium and Microsporidia infecting hematological
malignancy patients. Acta Parasitologica, 66, 508–516.
Lores, B., Lopez-Miragaya, I., Arias, C., Fenoy, S., Torres, J. and del Aguila,C. (2002): Intestinal microsporidiosis due to Enterocytozoon bieneusi in elderly human immunodeficiency virus-negative patients from Vigo, Spain. Clinical Infectious Diseases. 34:918-921.
Han B, Pan G, Weiss LM. (2021): Microsporidiosis in humans. Clinical Microbiology
Reviews, 34, e0001020.
Ismail KA, Hawash YA, Saber T, Eed EM, Khalifa AS, Alsharif KF, Alghamdi SA, Khalifa
AM, Khalifa OM, Althubiti HK, Alsofyani GM. (2020): Microsporidia infection in patients
with autoimmune diseases. Indian Journal of Medical Microbiology, 38, 409–414.
Karimi K, Mirjalali H, Niyyati M, Haghighi A, Pourhoseingholi MA, Sharifdini M, Naderi
N, Zali MR. (2020): Molecular epidemiology of Enterocytozoon bieneusi and
Encephalitozoon sp., among immunocompromised and immunocompetent subjects in Iran.
Microbial Pathogenesis, 141, 103988.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.